Diagnosis in neurosurgery

Remote intra-operative diagnosis in neurosurgery

Graham McHardy CSci FIBMS Department of Pathology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, UK   The introduction of digital slide scanning for remote reporting has restored an important service for patient healthcare at a Scottish hospital Telepathology is the process of digitising histological images for transmission electronically to remote centres, often for the purposes of diagnosis. Some telepathology systems employ robotic microscopes, which can be controlled remotely in order …

Algorics

Press-release: Mednet Solutions announces technology partnership with Algorics

May 19, 2016 Minnetonka, Minn. & Houston, Texas – MedNet Solutions, an innovative SaaS-based eClinical technology company that supports the entire spectrum of clinical research, and Algorics, a provider of cloud-based clinical analytics solutions and software for the global life sciences industry, today unveiled their strategic technology partnership designed to provide superior risk based monitoring (RBM) functionality to MedNet’s customers …

Abbot Laboratories Whitepaper

Whitepaper: Considerations in Purchasing a LIMS

Randy C. Hice | Abbot Laboratories Many scientific enterprises find themselves in need of a Laboratory Information Management System (LIMS) to replace an incumbent system, whether an existing commercial application, an amalgam of systems, or an in-house solution. Once the decision has been made, the selection and deployment of a new LIMS should move quickly and decisively. This white paper …

genomeweb whitepaper

Alternative Proposals for Lab Test Regulation

Are There Opportunities for Consensus? A GenomeWeb Report February 2016 Amid multiple proposals on LDT regulation, are there opportunities for consensus? By Turna Ray The lab industry entered 2016 in a staring contest with the US Food and Drug Administration that began two years ago when the agency released its draft guidance on regulating laboratory-developed tests (LDTs). During the course …

Clinical Outsourcing

Recoding the Life Sciences Value Chain with Digital DNA

Take a look at the penetration of digital technologies within and across the life sciences value chain, and see how some organizations are digitally reimagining their businesses to drive growth, boost productivity. Life sciences companies need to generate higher revenues at reduced costs to sustain innovation. To achieve this optimal scenario, the industry is building new portfolios, expanding into new geographies, …

TCS whitepaper

Reimagining the Clinical Trials Process through Digital Disruption

Conventional clinical trial processes require significant time and resources to be invested for data cleaning, monitoring, and reporting to the concerned regulatory authorities. This directly influences the cost of the trial, and thus the time to market. Explore how digitization of clinical trial processes can help transform the clinical research industry. The clinical trials industry manages large volumes of patient data …

Essential payer insights

Using real world evidence in clinical trials is critical to the success of patient recruitment and payer engagement programs. Through more stakeholder collaboration, we can help patients access the right treatment for them. How can we achieve this in practice? How do we overcome pricing and funding challenges? How can we use data better? We put these important questions to …

lexisnexis whitepaper

Download whitepaper – Pharmaceutical & Life sciences: Third Party Due Diligence

Whitepaper by LexisNexis Few industries are as exposed to risk as the pharmaceuticals and life sciences. It is no longer enough to carry out basic checks alone on third-parties. Companies must engage in enhanced due diligence if they are to avoid the large fines and regulatory penalties. Effective third-party due diligence is increasingly recognized as a strategic driver for sustainable …

GaBI online

Tentative FDA approval for chemotherapy generic

Aurobindo Pharma (Aurobindo) has received tentative US Food and Drug Administration (FDA) approval for chemotherapy generic palonosetron. The Indian generics maker received tentative FDA approval for its generic injectable intravenous palonosetron at a dosage of 0.25 mg/5 mL on 4 November 2015. The originator product Aloxi/Onicit/Paloxi (palonosetron) is manufactured by Helsinn Birex Pharmaceuticals and was approved by FDA on 25 …

algorics whitepaper

Is risk based monitoring (RBM) an opportunity or challenge for mid-size CROs?

Abby Abraham, Vice-President – Clinical Solutions Nicholas Hargaden, President October 2015 www.algorics.com The adoption of risk based monitoring (RBM) in sponsored clinical trials has been driven by both regulators and industry bodies such as Transcelerate and Metrics Champion Consortium (MCC). Amongst the larger pharmaceutical companies and CROs, significant pilot programs have been completed and in some cases a broader roll …